Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
ESMO 2022: Highlights, commentary and analysis
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2022: Highlights, commentary and analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
12 Sep 2022
Abemaciclib plus NSAI for HR+, HER2- advanced breast cancer - MONARCH 3 interim ...
Prof Matthew P Goetz - Mayo Clinic, Rochester, USA
Abemaciclib plus NSAI for HR+, HER2- advanced breast cancer - MONARCH 3 interim data ( Prof Matthew P Goetz - Mayo Clinic, Rochester, USA )
12 Sep 2022
Results from a phase 3 study of 1L atezolizumab vs single-agent chemotherapy in ...
Prof Siow-Ming Lee - University College London, London, UK
Results from a phase 3 study of 1L atezolizumab vs single-agent chemotherapy in pts with NSCLC ( Prof Siow-Ming Lee - University College London, London, UK )
12 Sep 2022
RADICALS-HD trial: androgen deprivation therapy with post-operative radiotherapy...
Prof Chris Parker - Institute of Cancer Research, Sutton, UK
RADICALS-HD trial: androgen deprivation therapy with post-operative radiotherapy to treat prostate cancer ( Prof Chris Parker - Institute of Cancer Research, Sutton, UK )
12 Sep 2022
Nivolumab ipilimumab combo does not improve DFS for RCC after nephrectomy
Dr Robert Motzer - Memorial Sloan Kettering Cancer Center, New York, USA
Nivolumab ipilimumab combo does not improve DFS for RCC after nephrectomy ( Dr Robert Motzer - Memorial Sloan Kettering Cancer Center, New York, USA )
11 Sep 2022
Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine t...
Dr Vivianne Tjan-Heijnen - Maastricht University Medical Center, Maastricht, Net...
Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine therapy ( Dr Vivianne Tjan-Heijnen - Maastricht University Medical Center, Maastricht, Netherlands )
11 Sep 2022
OncoAlert and ecancer weekly round up for August 15th - 21st, 2022
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for August 15th - 21st, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
22 Aug 2022
What's new in molecular targeted treatments for EGFR mutant NSCLC
Dr Keith Kerr, Dr Melina Marmarelis, Prof Amanda Tufman and Dr Jordi Remón Masip
What's new in molecular targeted treatments for EGFR mutant NSCLC ( Dr Keith Kerr, Dr Melina Marmarelis, Prof Amanda Tufman and Dr Jordi Remón Masip )
12 Aug 2022
Global obstacles to lung cancer screening: Report
Professor Rudolf Huber - The Hospital of the University of Munich, Munich, Germ...
Global obstacles to lung cancer screening: Report ( Professor Rudolf Huber - The Hospital of the University of Munich,  Munich, Germany )
11 Aug 2022
IASLC Early Detection and Screening Committee: Global obstacles to lung cancer s...
Dr Milena Cavic - Institute for Oncology and Radiology of Serbia, Belgrade, Serb...
IASLC Early Detection and Screening Committee: Global obstacles to lung cancer screening ( Dr Milena Cavic - Institute for Oncology and Radiology of Serbia, Belgrade, Serbia )
11 Aug 2022
Personalised smoking cessation support in a lung cancer screening programme
Dr Rachael Murray - The University of Nottingham, Nottingham, UK
Personalised smoking cessation support in a lung cancer screening programme ( Dr Rachael Murray - The University of Nottingham, Nottingham, UK )
11 Aug 2022
Early diagnosis needed for young adults with lung cancer
Alexandra Potter - Massachusetts General Hospital, Boston, USA
Early diagnosis needed for young adults with lung cancer ( Alexandra Potter - Massachusetts General Hospital, Boston, USA )
11 Aug 2022